Cytokine release syndrome in a patient with colorectal cancer after vaccination with BNT162b2

被引:78
作者
Au, Lewis [1 ,2 ,3 ]
Fendler, Annika [1 ]
Shepherd, Scott T. C. [1 ,2 ,3 ]
Rzeniewicz, Karolina [1 ]
Cerrone, Maddalena [4 ,5 ]
Byrne, Fiona [1 ]
Carlyle, Eleanor [2 ,3 ]
Edmonds, Kim [2 ,3 ]
Del Rosario, Lyra [2 ,3 ]
Shon, John [6 ]
Haynes, Winston A. [6 ]
Ward, Barry [1 ]
Shum, Ben [1 ,2 ,3 ]
Gordon, William [1 ]
Gerard, Camille L. [1 ,7 ]
Xie, Wenyi [1 ]
Joharatnam-Hogan, Nalinie [2 ,3 ]
Young, Kate [2 ,3 ]
Pickering, Lisa [2 ,3 ]
Furness, Andrew J. S. [2 ,3 ]
Larkin, James [2 ,3 ]
Harvey, Ruth [8 ]
Kassiotis, George [9 ]
Gandhi, Sonia [10 ,11 ]
Swanton, Charles [12 ]
Fribbens, Charlotte [12 ,13 ,14 ]
Wilkinson, Katalin A. [4 ]
Wilkinson, Robert J. [4 ,5 ]
Lau, David K. [14 ]
Banerjee, Susana [15 ,16 ]
Starling, Naureen [14 ]
Chau, Ian [14 ]
Turajlic, Samra [1 ,2 ,3 ]
机构
[1] Francis Crick Inst, Canc Dynam Lab, London, England
[2] Royal Marsden NHS Fdn Trust, Skin Unit, London, England
[3] Royal Marsden NHS Fdn Trust, Renal Unit, London, England
[4] Francis Crick Inst, TB Lab, London, England
[5] Imperial Coll London, Dept Infect Dis, London, England
[6] Serimmune Inc, Goleta, CA USA
[7] Lausanne Univ Hosp CHUV, Precis Oncol Ctr, Lausanne, Switzerland
[8] Francis Crick Inst, Worldwide Influenza Ctr, London, England
[9] Francis Crick Inst, Retroviral Immunol Lab, London, England
[10] Francis Crick Inst, Neurodegenerat Biol Lab, London, England
[11] UCL Queen Sq Inst Neurol, Queen Sq, London, England
[12] Francis Crick Inst, Canc Evolut & Genome Instabil Lab, London, England
[13] Royal Marsden NHS Fdn Trust, Acute Oncol Serv, London, England
[14] Royal Marsden NHS Fdn Trust, Gastrointestinal & Lymphoma Unit, Sutton, Surrey, England
[15] Royal Marsden NHS Fdn Trust, Gynaecol Unit, London, England
[16] Inst Canc Res, London, England
基金
英国医学研究理事会; 英国惠康基金;
关键词
RESPONSES; COVID-19; SAFETY;
D O I
10.1038/s41591-021-01387-6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A rare case of cytokine release syndrome in a patient on anti-PD-1 blockade that was likely related to BNT162b2 vaccination supports prospective monitoring of patients with cancer after COVID-19 vaccine administration. Patients with cancer are currently prioritized in coronavirus disease 2019 (COVID-19) vaccination programs globally, which includes administration of mRNA vaccines. Cytokine release syndrome (CRS) has not been reported with mRNA vaccines and is an extremely rare immune-related adverse event of immune checkpoint inhibitors. We present a case of CRS that occurred 5 d after vaccination with BTN162b2 (tozinameran)-the Pfizer-BioNTech mRNA COVID-19 vaccine-in a patient with colorectal cancer on long-standing anti-PD-1 monotherapy. The CRS was evidenced by raised inflammatory markers, thrombocytopenia, elevated cytokine levels (IFN-gamma/IL-2R/IL-18/IL-16/IL-10) and steroid responsiveness. The close temporal association of vaccination and diagnosis of CRS in this case suggests that CRS was a vaccine-related adverse event; with anti-PD1 blockade as a potential contributor. Overall, further prospective pharmacovigillence data are needed in patients with cancer, but the benefit-risk profile remains strongly in favor of COVID-19 vaccination in this population.
引用
收藏
页码:1362 / +
页数:11
相关论文
共 26 条
[11]   Thrombocytopenia following Pfizer and Moderna SARS-CoV-2 vaccination [J].
Lee, Eun-Ju ;
Cines, Douglas B. ;
Gernsheimer, Terry ;
Kessler, Craig ;
Michel, Marc ;
Tarantino, Michael D. ;
Semple, John W. ;
Arnold, Donald M. ;
Godeau, Bertrand ;
Lambert, Michele P. ;
Bussel, James B. .
AMERICAN JOURNAL OF HEMATOLOGY, 2021, 96 (05) :534-537
[12]   Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study [J].
Monin, Leticia ;
Laing, Adam G. ;
Munoz-Ruiz, Miguel ;
McKenzie, Duncan R. ;
Del Barrio, Irene Del Molino ;
Alaguthurai, Thanussuyah ;
Domingo-Vila, Clara ;
Hayday, Thomas S. ;
Graham, Carl ;
Seow, Jeffrey ;
Abdul-Jawad, Sultan ;
Kamdar, Shraddha ;
Harvey-Jones, Elizabeth ;
Graham, Rosalind ;
Cooper, Jack ;
Khan, Muhammad ;
Vidler, Jennifer ;
Kakkassery, Helen ;
Sinha, Shubhankar ;
Davis, Richard ;
Dupont, Liane ;
Quijorna, Isaac Francos ;
O'Brien-Gore, Charlotte ;
Lee, Puay Ling ;
Eum, Josephine ;
Poole, Maria Conde ;
Joseph, Magdalene ;
Davies, Daniel ;
Wu, Yin ;
Swampillai, Angela ;
North, Bernard, V ;
Montes, Ana ;
Harries, Mark ;
Rigg, Anne ;
Spicer, James ;
Malim, Michael H. ;
Fields, Paul ;
Patten, Piers ;
Di Rosa, Francesca ;
Papa, Sophie ;
Tree, Timothy ;
Doores, Katie J. ;
Hayday, Adrian C. ;
Irshad, Sheeba .
LANCET ONCOLOGY, 2021, 22 (06) :765-778
[13]   Chimeric antigen receptor T-cell therapy - assessment and management of toxicities [J].
Neelapu, Sattva S. ;
Tummala, Sudhakar ;
Kebriaei, Partow ;
Wierda, William ;
Gutierrez, Cristina ;
Locke, Frederick L. ;
Komanduri, Krishna V. ;
Lin, Yi ;
Jain, Nitin ;
Daver, Naval ;
Westin, Jason ;
Gulbis, Alison M. ;
Loghin, Monica E. ;
de Groot, John F. ;
Adkins, Sherry ;
Davis, Suzanne E. ;
Rezvani, Katayoun ;
Hwu, Patrick ;
Shpall, Elizabeth J. .
NATURE REVIEWS CLINICAL ONCOLOGY, 2018, 15 (01) :47-62
[14]  
Postow MA, 2018, NEW ENGL J MED, V378, P158, DOI [10.1056/NEJMc1801663, 10.1056/NEJMra1703481]
[15]   Effect of previous SARS-CoV-2 infection on humoral and T-cell responses to single-dose BNT162b2 vaccine [J].
Prendecki, Maria ;
Clarke, Candice ;
Brown, Jonathan ;
Cox, Alison ;
Gleeson, Sarah ;
Guckian, Mary ;
Randell, Paul ;
Dalla Pria, Alessia ;
Lightstone, Liz ;
Xu, Xiao-Ning ;
Barclay, Wendy ;
McAdoo, Stephen P. ;
Kelleher, Peter ;
Willicombe, Michelle .
LANCET, 2021, 397 (10280) :1178-1181
[16]  
Reifert J, 2021, J CLIN MICROBIOL, V59, DOI [10.1128/jcm.01836-20, 10.1128/JCM.01836-20]
[17]   Priority COVID-19 Vaccination for Patients with Cancer while Vaccine Supply Is Limited [J].
Ribas, Antoni ;
Sengupta, Rajarshi ;
Locke, Trevan ;
Zaidi, Sayyed Kaleem ;
Campbell, Katie M. ;
Carethers, John M. ;
Jaffee, Elizabeth M. ;
Wherry, E. John ;
Soria, Jean-Charles ;
D'Souza, Gypsyamber .
CANCER DISCOVERY, 2021, 11 (02) :233-236
[18]   An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma [J].
Sahin, Ugur ;
Oehm, Petra ;
Derhovanessian, Evelyna ;
Jabulowsky, Robert A. ;
Vormehr, Mathias ;
Gold, Maike ;
Maurus, Daniel ;
Schwarck-Kokarakis, Doreen ;
Kuhn, Andreas N. ;
Omokoko, Tana ;
Kranz, Lena M. ;
Diken, Mustafa ;
Kreiter, Sebastian ;
Haas, Heinrich ;
Attig, Sebastian ;
Rae, Richard ;
Cuk, Katarina ;
Kemmer-Brueck, Alexandra ;
Breitkreuz, Andrea ;
Tolliver, Claudia ;
Caspar, Janina ;
Quinkhardt, Juliane ;
Hebich, Lisa ;
Stein, Malte ;
Hohberger, Alexander ;
Vogler, Isabel ;
Liebig, Inga ;
Renken, Stephanie ;
Sikorski, Julian ;
Leierer, Melanie ;
Mueller, Verena ;
Mitzel-Rink, Heidrun ;
Miederer, Matthias ;
Huber, Christoph ;
Grabbe, Stephan ;
Utikal, Jochen ;
Pinter, Andreas ;
Kaufmann, Roland ;
Hassel, Jessica C. ;
Loquai, Carmen ;
Tuereci, Oezlem .
NATURE, 2020, 585 (7823) :107-+
[19]  
Schultz NH, 2021, NEW ENGL J MED, V384, P2124, DOI [10.1056/NEJMoa2104840, 10.1056/NEJMoa2104882]
[20]   Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination [J].
Scully, Marie ;
Singh, Deepak ;
Lown, Robert ;
Poles, Anthony ;
Solomon, Tom ;
Levi, Marcel ;
Goldblatt, David ;
Kotoucek, Pavel ;
Thomas, William ;
Lester, William .
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (23) :2202-2211